nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB2—stomach cancer	0.321	0.679	CbGaD
Lapatinib—EGFR—stomach cancer	0.152	0.321	CbGaD
Lapatinib—EGFR—Docetaxel—stomach cancer	0.123	0.503	CbGbCtD
Lapatinib—ABCB1—Mitomycin—stomach cancer	0.039	0.159	CbGbCtD
Lapatinib—CYP3A5—Irinotecan—stomach cancer	0.0154	0.0628	CbGbCtD
Lapatinib—CYP2C8—Fluorouracil—stomach cancer	0.0142	0.058	CbGbCtD
Lapatinib—CYP3A5—Docetaxel—stomach cancer	0.0113	0.046	CbGbCtD
Lapatinib—ABCB1—Irinotecan—stomach cancer	0.01	0.0409	CbGbCtD
Lapatinib—ABCB1—Docetaxel—stomach cancer	0.00733	0.03	CbGbCtD
Lapatinib—CYP3A4—Irinotecan—stomach cancer	0.00599	0.0245	CbGbCtD
Lapatinib—ABCB1—Doxorubicin—stomach cancer	0.00546	0.0223	CbGbCtD
Lapatinib—ABCB1—Methotrexate—stomach cancer	0.00529	0.0216	CbGbCtD
Lapatinib—CYP3A4—Docetaxel—stomach cancer	0.00439	0.018	CbGbCtD
Lapatinib—CYP3A4—Doxorubicin—stomach cancer	0.00327	0.0134	CbGbCtD
Lapatinib—ERBB2—gall bladder—stomach cancer	0.00313	0.0671	CbGeAlD
Lapatinib—PIK3C2B—hematopoietic system—stomach cancer	0.00228	0.0488	CbGeAlD
Lapatinib—TAP1—pancreas—stomach cancer	0.00197	0.0424	CbGeAlD
Lapatinib—PIK3C2B—pancreas—stomach cancer	0.00185	0.0398	CbGeAlD
Lapatinib—ERBB2—hematopoietic system—stomach cancer	0.00177	0.038	CbGeAlD
Lapatinib—Gefitinib—CHEK2—stomach cancer	0.0017	0.655	CrCbGaD
Lapatinib—ERBB2—epithelium—stomach cancer	0.00162	0.0347	CbGeAlD
Lapatinib—ERBB4—epithelium—stomach cancer	0.00162	0.0347	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—stomach cancer	0.00156	0.0335	CbGeAlD
Lapatinib—TAP1—bone marrow—stomach cancer	0.00155	0.0333	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—stomach cancer	0.00146	0.0313	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—stomach cancer	0.00146	0.0313	CbGeAlD
Lapatinib—ERBB2—pancreas—stomach cancer	0.00144	0.0309	CbGeAlD
Lapatinib—PIK3C2B—Topotecan—Irinotecan—stomach cancer	0.00143	0.455	CbGdCrCtD
Lapatinib—PI4KB—pancreas—stomach cancer	0.00135	0.029	CbGeAlD
Lapatinib—PIK3C2B—endocrine gland—stomach cancer	0.00131	0.0281	CbGeAlD
Lapatinib—TAP1—liver—stomach cancer	0.00126	0.0269	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—stomach cancer	0.00125	0.0267	CbGeAlD
Lapatinib—ERBB2—digestive system—stomach cancer	0.00123	0.0264	CbGeAlD
Lapatinib—PIK3C2B—liver—stomach cancer	0.00118	0.0253	CbGeAlD
Lapatinib—ERBB2—Topotecan—Irinotecan—stomach cancer	0.00117	0.375	CbGdCrCtD
Lapatinib—PI4KB—bone marrow—stomach cancer	0.00106	0.0228	CbGeAlD
Lapatinib—ERBB2—endocrine gland—stomach cancer	0.00102	0.0218	CbGeAlD
Lapatinib—ERBB4—endocrine gland—stomach cancer	0.00102	0.0218	CbGeAlD
Lapatinib—TAP1—lymph node—stomach cancer	0.000963	0.0207	CbGeAlD
Lapatinib—PI4KB—endocrine gland—stomach cancer	0.000953	0.0204	CbGeAlD
Lapatinib—ERBB2—liver—stomach cancer	0.000917	0.0197	CbGeAlD
Lapatinib—PIK3C2B—lymph node—stomach cancer	0.000904	0.0194	CbGeAlD
Lapatinib—PI4KB—liver—stomach cancer	0.000859	0.0184	CbGeAlD
Lapatinib—EGFR—liver—stomach cancer	0.000778	0.0167	CbGeAlD
Lapatinib—ERBB2—lymph node—stomach cancer	0.000703	0.0151	CbGeAlD
Lapatinib—Gefitinib—EGFR—stomach cancer	0.00068	0.262	CrCbGaD
Lapatinib—PI4KB—lymph node—stomach cancer	0.000659	0.0141	CbGeAlD
Lapatinib—EGFR—lymph node—stomach cancer	0.000596	0.0128	CbGeAlD
Lapatinib—CYP2C19—hematopoietic system—stomach cancer	0.000551	0.0118	CbGeAlD
Lapatinib—CYP2C8—hematopoietic system—stomach cancer	0.000481	0.0103	CbGeAlD
Lapatinib—CYP3A5—hematopoietic system—stomach cancer	0.000434	0.00932	CbGeAlD
Lapatinib—ABCB1—blood vessel—stomach cancer	0.000433	0.00929	CbGeAlD
Lapatinib—CYP2C19—digestive system—stomach cancer	0.000383	0.00822	CbGeAlD
Lapatinib—CYP3A5—pancreas—stomach cancer	0.000354	0.00759	CbGeAlD
Lapatinib—CYP3A4—hematopoietic system—stomach cancer	0.000326	0.00699	CbGeAlD
Lapatinib—CYP2C19—endocrine gland—stomach cancer	0.000317	0.0068	CbGeAlD
Lapatinib—CYP3A5—digestive system—stomach cancer	0.000302	0.00648	CbGeAlD
Lapatinib—CYP2C19—liver—stomach cancer	0.000286	0.00613	CbGeAlD
Lapatinib—CYP2C8—endocrine gland—stomach cancer	0.000277	0.00593	CbGeAlD
Lapatinib—ERBB2—Doxorubicin—Epirubicin—stomach cancer	0.000276	0.0881	CbGdCrCtD
Lapatinib—ERBB2—Epirubicin—Doxorubicin—stomach cancer	0.000255	0.0816	CbGdCrCtD
Lapatinib—CYP3A5—endocrine gland—stomach cancer	0.00025	0.00535	CbGeAlD
Lapatinib—CYP2C8—liver—stomach cancer	0.000249	0.00535	CbGeAlD
Lapatinib—ABCB1—hematopoietic system—stomach cancer	0.000231	0.00495	CbGeAlD
Lapatinib—CYP3A4—digestive system—stomach cancer	0.000227	0.00486	CbGeAlD
Lapatinib—CYP3A5—liver—stomach cancer	0.000225	0.00483	CbGeAlD
Lapatinib—Gefitinib—ALB—stomach cancer	0.000217	0.0834	CrCbGaD
Lapatinib—ABCB1—epithelium—stomach cancer	0.000211	0.00452	CbGeAlD
Lapatinib—ABCB1—pancreas—stomach cancer	0.000188	0.00403	CbGeAlD
Lapatinib—CYP3A4—endocrine gland—stomach cancer	0.000187	0.00402	CbGeAlD
Lapatinib—CYP3A4—liver—stomach cancer	0.000169	0.00362	CbGeAlD
Lapatinib—ABCB1—lymphoid tissue—stomach cancer	0.000162	0.00348	CbGeAlD
Lapatinib—ABCB1—digestive system—stomach cancer	0.00016	0.00344	CbGeAlD
Lapatinib—ABCB1—bone marrow—stomach cancer	0.000148	0.00317	CbGeAlD
Lapatinib—Dyspepsia—Irinotecan—stomach cancer	0.000137	0.00125	CcSEcCtD
Lapatinib—Immune system disorder—Docetaxel—stomach cancer	0.000137	0.00124	CcSEcCtD
Lapatinib—Pain in extremity—Doxorubicin—stomach cancer	0.000137	0.00124	CcSEcCtD
Lapatinib—Mediastinal disorder—Docetaxel—stomach cancer	0.000137	0.00124	CcSEcCtD
Lapatinib—Cardiac disorder—Capecitabine—stomach cancer	0.000136	0.00124	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000136	0.00123	CcSEcCtD
Lapatinib—Dry skin—Epirubicin—stomach cancer	0.000136	0.00123	CcSEcCtD
Lapatinib—Decreased appetite—Irinotecan—stomach cancer	0.000136	0.00123	CcSEcCtD
Lapatinib—Insomnia—Fluorouracil—stomach cancer	0.000135	0.00123	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000135	0.00122	CcSEcCtD
Lapatinib—Fatigue—Irinotecan—stomach cancer	0.000134	0.00122	CcSEcCtD
Lapatinib—Alopecia—Docetaxel—stomach cancer	0.000134	0.00122	CcSEcCtD
Lapatinib—Constipation—Irinotecan—stomach cancer	0.000133	0.00121	CcSEcCtD
Lapatinib—Angiopathy—Capecitabine—stomach cancer	0.000133	0.00121	CcSEcCtD
Lapatinib—Dyspnoea—Fluorouracil—stomach cancer	0.000133	0.00121	CcSEcCtD
Lapatinib—Mental disorder—Docetaxel—stomach cancer	0.000133	0.00121	CcSEcCtD
Lapatinib—Immune system disorder—Capecitabine—stomach cancer	0.000133	0.0012	CcSEcCtD
Lapatinib—ABCB1—endocrine gland—stomach cancer	0.000133	0.00284	CbGeAlD
Lapatinib—Mediastinal disorder—Capecitabine—stomach cancer	0.000132	0.0012	CcSEcCtD
Lapatinib—Malnutrition—Docetaxel—stomach cancer	0.000132	0.0012	CcSEcCtD
Lapatinib—Dyspepsia—Fluorouracil—stomach cancer	0.000131	0.00119	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.00013	0.00118	CcSEcCtD
Lapatinib—Decreased appetite—Fluorouracil—stomach cancer	0.00013	0.00118	CcSEcCtD
Lapatinib—Alopecia—Capecitabine—stomach cancer	0.00013	0.00118	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000129	0.00117	CcSEcCtD
Lapatinib—Mental disorder—Capecitabine—stomach cancer	0.000129	0.00117	CcSEcCtD
Lapatinib—Malnutrition—Capecitabine—stomach cancer	0.000128	0.00116	CcSEcCtD
Lapatinib—Back pain—Docetaxel—stomach cancer	0.000128	0.00116	CcSEcCtD
Lapatinib—Neutropenia—Methotrexate—stomach cancer	0.000128	0.00116	CcSEcCtD
Lapatinib—Gastrointestinal pain—Irinotecan—stomach cancer	0.000127	0.00116	CcSEcCtD
Lapatinib—Dehydration—Doxorubicin—stomach cancer	0.000127	0.00116	CcSEcCtD
Lapatinib—Dry skin—Doxorubicin—stomach cancer	0.000125	0.00114	CcSEcCtD
Lapatinib—Back pain—Capecitabine—stomach cancer	0.000124	0.00112	CcSEcCtD
Lapatinib—Abdominal pain—Irinotecan—stomach cancer	0.000123	0.00112	CcSEcCtD
Lapatinib—Pneumonia—Methotrexate—stomach cancer	0.000122	0.00111	CcSEcCtD
Lapatinib—Anaemia—Docetaxel—stomach cancer	0.000122	0.00111	CcSEcCtD
Lapatinib—Infestation NOS—Methotrexate—stomach cancer	0.000122	0.00111	CcSEcCtD
Lapatinib—Infestation—Methotrexate—stomach cancer	0.000122	0.00111	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000121	0.0011	CcSEcCtD
Lapatinib—ABCB1—liver—stomach cancer	0.00012	0.00256	CbGeAlD
Lapatinib—Neutropenia—Epirubicin—stomach cancer	0.00012	0.00108	CcSEcCtD
Lapatinib—Stomatitis—Methotrexate—stomach cancer	0.000119	0.00108	CcSEcCtD
Lapatinib—Leukopenia—Docetaxel—stomach cancer	0.000118	0.00107	CcSEcCtD
Lapatinib—Anaemia—Capecitabine—stomach cancer	0.000118	0.00107	CcSEcCtD
Lapatinib—Palpitations—Docetaxel—stomach cancer	0.000117	0.00106	CcSEcCtD
Lapatinib—Cough—Docetaxel—stomach cancer	0.000115	0.00105	CcSEcCtD
Lapatinib—Hepatobiliary disease—Methotrexate—stomach cancer	0.000115	0.00105	CcSEcCtD
Lapatinib—Epistaxis—Methotrexate—stomach cancer	0.000115	0.00104	CcSEcCtD
Lapatinib—Hypersensitivity—Irinotecan—stomach cancer	0.000115	0.00104	CcSEcCtD
Lapatinib—Pneumonia—Epirubicin—stomach cancer	0.000115	0.00104	CcSEcCtD
Lapatinib—Leukopenia—Capecitabine—stomach cancer	0.000114	0.00104	CcSEcCtD
Lapatinib—Infestation NOS—Epirubicin—stomach cancer	0.000114	0.00103	CcSEcCtD
Lapatinib—Infestation—Epirubicin—stomach cancer	0.000114	0.00103	CcSEcCtD
Lapatinib—Palpitations—Capecitabine—stomach cancer	0.000113	0.00103	CcSEcCtD
Lapatinib—Arthralgia—Docetaxel—stomach cancer	0.000112	0.00102	CcSEcCtD
Lapatinib—Myalgia—Docetaxel—stomach cancer	0.000112	0.00102	CcSEcCtD
Lapatinib—Asthenia—Irinotecan—stomach cancer	0.000112	0.00102	CcSEcCtD
Lapatinib—Neuropathy peripheral—Epirubicin—stomach cancer	0.000112	0.00101	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000112	0.00101	CcSEcCtD
Lapatinib—Cough—Capecitabine—stomach cancer	0.000112	0.00101	CcSEcCtD
Lapatinib—Stomatitis—Epirubicin—stomach cancer	0.000111	0.00101	CcSEcCtD
Lapatinib—Neutropenia—Doxorubicin—stomach cancer	0.000111	0.001	CcSEcCtD
Lapatinib—Hypersensitivity—Fluorouracil—stomach cancer	0.00011	0.000998	CcSEcCtD
Lapatinib—Myalgia—Capecitabine—stomach cancer	0.000109	0.000988	CcSEcCtD
Lapatinib—Arthralgia—Capecitabine—stomach cancer	0.000109	0.000988	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000108	0.000981	CcSEcCtD
Lapatinib—Hepatobiliary disease—Epirubicin—stomach cancer	0.000108	0.000978	CcSEcCtD
Lapatinib—Anaphylactic shock—Docetaxel—stomach cancer	0.000108	0.000978	CcSEcCtD
Lapatinib—Epistaxis—Epirubicin—stomach cancer	0.000107	0.000976	CcSEcCtD
Lapatinib—Infection—Docetaxel—stomach cancer	0.000107	0.000972	CcSEcCtD
Lapatinib—Diarrhoea—Irinotecan—stomach cancer	0.000107	0.000968	CcSEcCtD
Lapatinib—Pneumonia—Doxorubicin—stomach cancer	0.000106	0.000963	CcSEcCtD
Lapatinib—Nervous system disorder—Docetaxel—stomach cancer	0.000106	0.000959	CcSEcCtD
Lapatinib—Pruritus—Fluorouracil—stomach cancer	0.000106	0.000959	CcSEcCtD
Lapatinib—Infestation—Doxorubicin—stomach cancer	0.000105	0.000957	CcSEcCtD
Lapatinib—Infestation NOS—Doxorubicin—stomach cancer	0.000105	0.000957	CcSEcCtD
Lapatinib—Skin disorder—Docetaxel—stomach cancer	0.000105	0.00095	CcSEcCtD
Lapatinib—Infection—Capecitabine—stomach cancer	0.000104	0.000941	CcSEcCtD
Lapatinib—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000103	0.000938	CcSEcCtD
Lapatinib—Stomatitis—Doxorubicin—stomach cancer	0.000103	0.000933	CcSEcCtD
Lapatinib—Anorexia—Docetaxel—stomach cancer	0.000103	0.000932	CcSEcCtD
Lapatinib—Nervous system disorder—Capecitabine—stomach cancer	0.000102	0.000929	CcSEcCtD
Lapatinib—Diarrhoea—Fluorouracil—stomach cancer	0.000102	0.000927	CcSEcCtD
Lapatinib—Cardiac disorder—Methotrexate—stomach cancer	0.000101	0.000921	CcSEcCtD
Lapatinib—Skin disorder—Capecitabine—stomach cancer	0.000101	0.00092	CcSEcCtD
Lapatinib—Connective tissue disorder—Epirubicin—stomach cancer	0.000101	0.000913	CcSEcCtD
Lapatinib—Hepatobiliary disease—Doxorubicin—stomach cancer	9.97e-05	0.000905	CcSEcCtD
Lapatinib—Epistaxis—Doxorubicin—stomach cancer	9.95e-05	0.000903	CcSEcCtD
Lapatinib—Anorexia—Capecitabine—stomach cancer	9.94e-05	0.000903	CcSEcCtD
Lapatinib—Angiopathy—Methotrexate—stomach cancer	9.92e-05	0.0009	CcSEcCtD
Lapatinib—Vomiting—Irinotecan—stomach cancer	9.91e-05	0.0009	CcSEcCtD
Lapatinib—Immune system disorder—Methotrexate—stomach cancer	9.87e-05	0.000896	CcSEcCtD
Lapatinib—Mediastinal disorder—Methotrexate—stomach cancer	9.85e-05	0.000894	CcSEcCtD
Lapatinib—Rash—Irinotecan—stomach cancer	9.83e-05	0.000892	CcSEcCtD
Lapatinib—Dermatitis—Irinotecan—stomach cancer	9.82e-05	0.000891	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Docetaxel—stomach cancer	9.82e-05	0.000891	CcSEcCtD
Lapatinib—Headache—Irinotecan—stomach cancer	9.77e-05	0.000886	CcSEcCtD
Lapatinib—Insomnia—Docetaxel—stomach cancer	9.75e-05	0.000885	CcSEcCtD
Lapatinib—Alopecia—Methotrexate—stomach cancer	9.66e-05	0.000877	CcSEcCtD
Lapatinib—Dyspnoea—Docetaxel—stomach cancer	9.61e-05	0.000872	CcSEcCtD
Lapatinib—Mental disorder—Methotrexate—stomach cancer	9.58e-05	0.000869	CcSEcCtD
Lapatinib—Malnutrition—Methotrexate—stomach cancer	9.52e-05	0.000864	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.5e-05	0.000863	CcSEcCtD
Lapatinib—Cardiac disorder—Epirubicin—stomach cancer	9.49e-05	0.000862	CcSEcCtD
Lapatinib—Vomiting—Fluorouracil—stomach cancer	9.49e-05	0.000862	CcSEcCtD
Lapatinib—Dyspepsia—Docetaxel—stomach cancer	9.49e-05	0.000861	CcSEcCtD
Lapatinib—Insomnia—Capecitabine—stomach cancer	9.44e-05	0.000857	CcSEcCtD
Lapatinib—Rash—Fluorouracil—stomach cancer	9.41e-05	0.000854	CcSEcCtD
Lapatinib—Dermatitis—Fluorouracil—stomach cancer	9.4e-05	0.000854	CcSEcCtD
Lapatinib—Decreased appetite—Docetaxel—stomach cancer	9.37e-05	0.00085	CcSEcCtD
Lapatinib—Headache—Fluorouracil—stomach cancer	9.35e-05	0.000849	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Docetaxel—stomach cancer	9.3e-05	0.000844	CcSEcCtD
Lapatinib—Connective tissue disorder—Doxorubicin—stomach cancer	9.3e-05	0.000844	CcSEcCtD
Lapatinib—Dyspnoea—Capecitabine—stomach cancer	9.3e-05	0.000844	CcSEcCtD
Lapatinib—Fatigue—Docetaxel—stomach cancer	9.29e-05	0.000843	CcSEcCtD
Lapatinib—Angiopathy—Epirubicin—stomach cancer	9.28e-05	0.000842	CcSEcCtD
Lapatinib—Nausea—Irinotecan—stomach cancer	9.26e-05	0.00084	CcSEcCtD
Lapatinib—Immune system disorder—Epirubicin—stomach cancer	9.24e-05	0.000839	CcSEcCtD
Lapatinib—Mediastinal disorder—Epirubicin—stomach cancer	9.22e-05	0.000837	CcSEcCtD
Lapatinib—Constipation—Docetaxel—stomach cancer	9.21e-05	0.000836	CcSEcCtD
Lapatinib—Back pain—Methotrexate—stomach cancer	9.2e-05	0.000836	CcSEcCtD
Lapatinib—Dyspepsia—Capecitabine—stomach cancer	9.18e-05	0.000834	CcSEcCtD
Lapatinib—ABCB1—lymph node—stomach cancer	9.16e-05	0.00197	CbGeAlD
Lapatinib—Decreased appetite—Capecitabine—stomach cancer	9.07e-05	0.000823	CcSEcCtD
Lapatinib—Alopecia—Epirubicin—stomach cancer	9.04e-05	0.000821	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Capecitabine—stomach cancer	9.01e-05	0.000818	CcSEcCtD
Lapatinib—Fatigue—Capecitabine—stomach cancer	8.99e-05	0.000816	CcSEcCtD
Lapatinib—Mental disorder—Epirubicin—stomach cancer	8.96e-05	0.000814	CcSEcCtD
Lapatinib—Constipation—Capecitabine—stomach cancer	8.92e-05	0.00081	CcSEcCtD
Lapatinib—Malnutrition—Epirubicin—stomach cancer	8.91e-05	0.000808	CcSEcCtD
Lapatinib—Nausea—Fluorouracil—stomach cancer	8.87e-05	0.000805	CcSEcCtD
Lapatinib—Gastrointestinal pain—Docetaxel—stomach cancer	8.81e-05	0.0008	CcSEcCtD
Lapatinib—Anaemia—Methotrexate—stomach cancer	8.8e-05	0.000798	CcSEcCtD
Lapatinib—Cardiac disorder—Doxorubicin—stomach cancer	8.78e-05	0.000797	CcSEcCtD
Lapatinib—Back pain—Epirubicin—stomach cancer	8.61e-05	0.000782	CcSEcCtD
Lapatinib—Angiopathy—Doxorubicin—stomach cancer	8.59e-05	0.00078	CcSEcCtD
Lapatinib—Immune system disorder—Doxorubicin—stomach cancer	8.55e-05	0.000776	CcSEcCtD
Lapatinib—Gastrointestinal pain—Capecitabine—stomach cancer	8.53e-05	0.000774	CcSEcCtD
Lapatinib—Mediastinal disorder—Doxorubicin—stomach cancer	8.53e-05	0.000774	CcSEcCtD
Lapatinib—Abdominal pain—Docetaxel—stomach cancer	8.52e-05	0.000773	CcSEcCtD
Lapatinib—Leukopenia—Methotrexate—stomach cancer	8.52e-05	0.000773	CcSEcCtD
Lapatinib—Alopecia—Doxorubicin—stomach cancer	8.36e-05	0.000759	CcSEcCtD
Lapatinib—Cough—Methotrexate—stomach cancer	8.3e-05	0.000754	CcSEcCtD
Lapatinib—Mental disorder—Doxorubicin—stomach cancer	8.29e-05	0.000753	CcSEcCtD
Lapatinib—Abdominal pain—Capecitabine—stomach cancer	8.25e-05	0.000749	CcSEcCtD
Lapatinib—Malnutrition—Doxorubicin—stomach cancer	8.24e-05	0.000748	CcSEcCtD
Lapatinib—Anaemia—Epirubicin—stomach cancer	8.23e-05	0.000747	CcSEcCtD
Lapatinib—Myalgia—Methotrexate—stomach cancer	8.1e-05	0.000735	CcSEcCtD
Lapatinib—Arthralgia—Methotrexate—stomach cancer	8.1e-05	0.000735	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	8.05e-05	0.00073	CcSEcCtD
Lapatinib—Leukopenia—Epirubicin—stomach cancer	7.97e-05	0.000724	CcSEcCtD
Lapatinib—Back pain—Doxorubicin—stomach cancer	7.97e-05	0.000723	CcSEcCtD
Lapatinib—Hypersensitivity—Docetaxel—stomach cancer	7.94e-05	0.000721	CcSEcCtD
Lapatinib—Palpitations—Epirubicin—stomach cancer	7.87e-05	0.000714	CcSEcCtD
Lapatinib—Cough—Epirubicin—stomach cancer	7.77e-05	0.000705	CcSEcCtD
Lapatinib—Anaphylactic shock—Methotrexate—stomach cancer	7.77e-05	0.000705	CcSEcCtD
Lapatinib—Asthenia—Docetaxel—stomach cancer	7.73e-05	0.000702	CcSEcCtD
Lapatinib—Infection—Methotrexate—stomach cancer	7.72e-05	0.0007	CcSEcCtD
Lapatinib—Hypersensitivity—Capecitabine—stomach cancer	7.69e-05	0.000698	CcSEcCtD
Lapatinib—Pruritus—Docetaxel—stomach cancer	7.62e-05	0.000692	CcSEcCtD
Lapatinib—Nervous system disorder—Methotrexate—stomach cancer	7.62e-05	0.000691	CcSEcCtD
Lapatinib—Anaemia—Doxorubicin—stomach cancer	7.62e-05	0.000691	CcSEcCtD
Lapatinib—Arthralgia—Epirubicin—stomach cancer	7.58e-05	0.000688	CcSEcCtD
Lapatinib—Myalgia—Epirubicin—stomach cancer	7.58e-05	0.000688	CcSEcCtD
Lapatinib—Skin disorder—Methotrexate—stomach cancer	7.54e-05	0.000685	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	7.53e-05	0.000683	CcSEcCtD
Lapatinib—Asthenia—Capecitabine—stomach cancer	7.49e-05	0.000679	CcSEcCtD
Lapatinib—Anorexia—Methotrexate—stomach cancer	7.4e-05	0.000672	CcSEcCtD
Lapatinib—Pruritus—Capecitabine—stomach cancer	7.38e-05	0.00067	CcSEcCtD
Lapatinib—Leukopenia—Doxorubicin—stomach cancer	7.38e-05	0.00067	CcSEcCtD
Lapatinib—Diarrhoea—Docetaxel—stomach cancer	7.37e-05	0.000669	CcSEcCtD
Lapatinib—Palpitations—Doxorubicin—stomach cancer	7.28e-05	0.000661	CcSEcCtD
Lapatinib—Anaphylactic shock—Epirubicin—stomach cancer	7.27e-05	0.00066	CcSEcCtD
Lapatinib—Infection—Epirubicin—stomach cancer	7.22e-05	0.000655	CcSEcCtD
Lapatinib—Cough—Doxorubicin—stomach cancer	7.19e-05	0.000653	CcSEcCtD
Lapatinib—Diarrhoea—Capecitabine—stomach cancer	7.14e-05	0.000648	CcSEcCtD
Lapatinib—Nervous system disorder—Epirubicin—stomach cancer	7.13e-05	0.000647	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methotrexate—stomach cancer	7.08e-05	0.000642	CcSEcCtD
Lapatinib—Skin disorder—Epirubicin—stomach cancer	7.06e-05	0.000641	CcSEcCtD
Lapatinib—Insomnia—Methotrexate—stomach cancer	7.02e-05	0.000638	CcSEcCtD
Lapatinib—Arthralgia—Doxorubicin—stomach cancer	7.02e-05	0.000637	CcSEcCtD
Lapatinib—Myalgia—Doxorubicin—stomach cancer	7.02e-05	0.000637	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	6.97e-05	0.000632	CcSEcCtD
Lapatinib—Anorexia—Epirubicin—stomach cancer	6.93e-05	0.000629	CcSEcCtD
Lapatinib—Dyspnoea—Methotrexate—stomach cancer	6.92e-05	0.000628	CcSEcCtD
Lapatinib—Vomiting—Docetaxel—stomach cancer	6.85e-05	0.000622	CcSEcCtD
Lapatinib—Dyspepsia—Methotrexate—stomach cancer	6.84e-05	0.000621	CcSEcCtD
Lapatinib—Rash—Docetaxel—stomach cancer	6.79e-05	0.000617	CcSEcCtD
Lapatinib—Dermatitis—Docetaxel—stomach cancer	6.79e-05	0.000616	CcSEcCtD
Lapatinib—Decreased appetite—Methotrexate—stomach cancer	6.75e-05	0.000613	CcSEcCtD
Lapatinib—Headache—Docetaxel—stomach cancer	6.75e-05	0.000613	CcSEcCtD
Lapatinib—Anaphylactic shock—Doxorubicin—stomach cancer	6.72e-05	0.00061	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Methotrexate—stomach cancer	6.7e-05	0.000609	CcSEcCtD
Lapatinib—Fatigue—Methotrexate—stomach cancer	6.7e-05	0.000608	CcSEcCtD
Lapatinib—Infection—Doxorubicin—stomach cancer	6.68e-05	0.000606	CcSEcCtD
Lapatinib—Vomiting—Capecitabine—stomach cancer	6.63e-05	0.000602	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.62e-05	0.000601	CcSEcCtD
Lapatinib—Nervous system disorder—Doxorubicin—stomach cancer	6.59e-05	0.000599	CcSEcCtD
Lapatinib—Rash—Capecitabine—stomach cancer	6.58e-05	0.000597	CcSEcCtD
Lapatinib—Insomnia—Epirubicin—stomach cancer	6.57e-05	0.000597	CcSEcCtD
Lapatinib—Dermatitis—Capecitabine—stomach cancer	6.57e-05	0.000597	CcSEcCtD
Lapatinib—Headache—Capecitabine—stomach cancer	6.54e-05	0.000593	CcSEcCtD
Lapatinib—Skin disorder—Doxorubicin—stomach cancer	6.53e-05	0.000593	CcSEcCtD
Lapatinib—Dyspnoea—Epirubicin—stomach cancer	6.48e-05	0.000588	CcSEcCtD
Lapatinib—Anorexia—Doxorubicin—stomach cancer	6.41e-05	0.000582	CcSEcCtD
Lapatinib—Nausea—Docetaxel—stomach cancer	6.4e-05	0.000581	CcSEcCtD
Lapatinib—Dyspepsia—Epirubicin—stomach cancer	6.4e-05	0.000581	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methotrexate—stomach cancer	6.35e-05	0.000576	CcSEcCtD
Lapatinib—Decreased appetite—Epirubicin—stomach cancer	6.32e-05	0.000573	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Epirubicin—stomach cancer	6.27e-05	0.00057	CcSEcCtD
Lapatinib—Fatigue—Epirubicin—stomach cancer	6.27e-05	0.000569	CcSEcCtD
Lapatinib—Constipation—Epirubicin—stomach cancer	6.22e-05	0.000564	CcSEcCtD
Lapatinib—Nausea—Capecitabine—stomach cancer	6.2e-05	0.000562	CcSEcCtD
Lapatinib—Abdominal pain—Methotrexate—stomach cancer	6.14e-05	0.000557	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Doxorubicin—stomach cancer	6.13e-05	0.000556	CcSEcCtD
Lapatinib—Insomnia—Doxorubicin—stomach cancer	6.08e-05	0.000552	CcSEcCtD
Lapatinib—Dyspnoea—Doxorubicin—stomach cancer	6e-05	0.000544	CcSEcCtD
Lapatinib—Gastrointestinal pain—Epirubicin—stomach cancer	5.94e-05	0.000539	CcSEcCtD
Lapatinib—Dyspepsia—Doxorubicin—stomach cancer	5.92e-05	0.000537	CcSEcCtD
Lapatinib—Decreased appetite—Doxorubicin—stomach cancer	5.85e-05	0.000531	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.81e-05	0.000527	CcSEcCtD
Lapatinib—Fatigue—Doxorubicin—stomach cancer	5.8e-05	0.000526	CcSEcCtD
Lapatinib—Constipation—Doxorubicin—stomach cancer	5.75e-05	0.000522	CcSEcCtD
Lapatinib—Abdominal pain—Epirubicin—stomach cancer	5.75e-05	0.000522	CcSEcCtD
Lapatinib—Hypersensitivity—Methotrexate—stomach cancer	5.72e-05	0.000519	CcSEcCtD
Lapatinib—Asthenia—Methotrexate—stomach cancer	5.57e-05	0.000506	CcSEcCtD
Lapatinib—Gastrointestinal pain—Doxorubicin—stomach cancer	5.5e-05	0.000499	CcSEcCtD
Lapatinib—Pruritus—Methotrexate—stomach cancer	5.49e-05	0.000499	CcSEcCtD
Lapatinib—Hypersensitivity—Epirubicin—stomach cancer	5.35e-05	0.000486	CcSEcCtD
Lapatinib—Abdominal pain—Doxorubicin—stomach cancer	5.32e-05	0.000483	CcSEcCtD
Lapatinib—Diarrhoea—Methotrexate—stomach cancer	5.31e-05	0.000482	CcSEcCtD
Lapatinib—Asthenia—Epirubicin—stomach cancer	5.21e-05	0.000473	CcSEcCtD
Lapatinib—Pruritus—Epirubicin—stomach cancer	5.14e-05	0.000467	CcSEcCtD
Lapatinib—Diarrhoea—Epirubicin—stomach cancer	4.97e-05	0.000451	CcSEcCtD
Lapatinib—Hypersensitivity—Doxorubicin—stomach cancer	4.95e-05	0.00045	CcSEcCtD
Lapatinib—Vomiting—Methotrexate—stomach cancer	4.94e-05	0.000448	CcSEcCtD
Lapatinib—Rash—Methotrexate—stomach cancer	4.9e-05	0.000444	CcSEcCtD
Lapatinib—Dermatitis—Methotrexate—stomach cancer	4.89e-05	0.000444	CcSEcCtD
Lapatinib—Headache—Methotrexate—stomach cancer	4.87e-05	0.000442	CcSEcCtD
Lapatinib—Asthenia—Doxorubicin—stomach cancer	4.82e-05	0.000438	CcSEcCtD
Lapatinib—Pruritus—Doxorubicin—stomach cancer	4.76e-05	0.000432	CcSEcCtD
Lapatinib—Vomiting—Epirubicin—stomach cancer	4.62e-05	0.000419	CcSEcCtD
Lapatinib—Nausea—Methotrexate—stomach cancer	4.61e-05	0.000419	CcSEcCtD
Lapatinib—Diarrhoea—Doxorubicin—stomach cancer	4.6e-05	0.000418	CcSEcCtD
Lapatinib—Rash—Epirubicin—stomach cancer	4.58e-05	0.000416	CcSEcCtD
Lapatinib—Dermatitis—Epirubicin—stomach cancer	4.58e-05	0.000416	CcSEcCtD
Lapatinib—Headache—Epirubicin—stomach cancer	4.55e-05	0.000413	CcSEcCtD
Lapatinib—Nausea—Epirubicin—stomach cancer	4.32e-05	0.000392	CcSEcCtD
Lapatinib—Vomiting—Doxorubicin—stomach cancer	4.28e-05	0.000388	CcSEcCtD
Lapatinib—Rash—Doxorubicin—stomach cancer	4.24e-05	0.000385	CcSEcCtD
Lapatinib—Dermatitis—Doxorubicin—stomach cancer	4.24e-05	0.000385	CcSEcCtD
Lapatinib—Headache—Doxorubicin—stomach cancer	4.21e-05	0.000382	CcSEcCtD
Lapatinib—Nausea—Doxorubicin—stomach cancer	3.99e-05	0.000363	CcSEcCtD
Lapatinib—EGFR—Signaling Pathways—PPP2R1A—stomach cancer	4.06e-06	3.37e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1B—stomach cancer	4.05e-06	3.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6ST—stomach cancer	4.04e-06	3.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLIN2—stomach cancer	4.02e-06	3.34e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KRAS—stomach cancer	4.02e-06	3.34e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DPYD—stomach cancer	4.02e-06	3.34e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PIK3CA—stomach cancer	4e-06	3.32e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALOX5—stomach cancer	3.99e-06	3.31e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.99e-06	3.31e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1B—stomach cancer	3.98e-06	3.31e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTT1—stomach cancer	3.98e-06	3.3e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2A6—stomach cancer	3.94e-06	3.27e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DPYD—stomach cancer	3.92e-06	3.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CASP8—stomach cancer	3.92e-06	3.25e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CA2—stomach cancer	3.91e-06	3.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6R—stomach cancer	3.91e-06	3.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—MAPK1—stomach cancer	3.89e-06	3.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APC—stomach cancer	3.88e-06	3.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDH1—stomach cancer	3.87e-06	3.21e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RHOA—stomach cancer	3.86e-06	3.2e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCND1—stomach cancer	3.86e-06	3.2e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JUN—stomach cancer	3.85e-06	3.19e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	3.84e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKR1C3—stomach cancer	3.83e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CD44—stomach cancer	3.82e-06	3.17e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PGAM1—stomach cancer	3.81e-06	3.16e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NT5E—stomach cancer	3.81e-06	3.16e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCND1—stomach cancer	3.8e-06	3.15e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JUN—stomach cancer	3.79e-06	3.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMAD4—stomach cancer	3.77e-06	3.13e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—stomach cancer	3.76e-06	3.12e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PIK3CA—stomach cancer	3.75e-06	3.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—stomach cancer	3.75e-06	3.11e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO1—stomach cancer	3.73e-06	3.1e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1A—stomach cancer	3.73e-06	3.1e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—stomach cancer	3.7e-06	3.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PIK3CA—stomach cancer	3.7e-06	3.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—stomach cancer	3.69e-06	3.06e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1A—stomach cancer	3.68e-06	3.05e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.67e-06	3.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KRAS—stomach cancer	3.67e-06	3.05e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.64e-06	3.02e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK8—stomach cancer	3.64e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALDH7A1—stomach cancer	3.64e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PLCE1—stomach cancer	3.64e-06	3.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6R—stomach cancer	3.61e-06	2.99e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—stomach cancer	3.6e-06	2.99e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK8—stomach cancer	3.59e-06	2.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FYN—stomach cancer	3.58e-06	2.97e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTT1—stomach cancer	3.56e-06	2.95e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—stomach cancer	3.54e-06	2.94e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—stomach cancer	3.53e-06	2.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KRAS—stomach cancer	3.53e-06	2.92e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2A6—stomach cancer	3.51e-06	2.92e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—UMPS—stomach cancer	3.49e-06	2.89e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—stomach cancer	3.47e-06	2.88e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTT1—stomach cancer	3.47e-06	2.88e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2A6—stomach cancer	3.43e-06	2.85e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—stomach cancer	3.42e-06	2.84e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKR1C3—stomach cancer	3.42e-06	2.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—stomach cancer	3.39e-06	2.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—stomach cancer	3.38e-06	2.81e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—SERPINE1—stomach cancer	3.38e-06	2.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PIK3CA—stomach cancer	3.37e-06	2.8e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—stomach cancer	3.36e-06	2.79e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGFR2—stomach cancer	3.36e-06	2.79e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKR1C3—stomach cancer	3.34e-06	2.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO1—stomach cancer	3.33e-06	2.76e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—stomach cancer	3.33e-06	2.76e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—stomach cancer	3.32e-06	2.76e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—stomach cancer	3.31e-06	2.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CD44—stomach cancer	3.31e-06	2.75e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—stomach cancer	3.28e-06	2.72e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	3.28e-06	2.72e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—stomach cancer	3.27e-06	2.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB2—stomach cancer	3.27e-06	2.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—RHOA—stomach cancer	3.26e-06	2.7e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO1—stomach cancer	3.25e-06	2.7e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPP2R1A—stomach cancer	3.25e-06	2.7e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PDHA1—stomach cancer	3.24e-06	2.69e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ECHS1—stomach cancer	3.24e-06	2.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PIK3CA—stomach cancer	3.24e-06	2.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—stomach cancer	3.22e-06	2.67e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.21e-06	2.66e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTP1—stomach cancer	3.19e-06	2.64e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK3—stomach cancer	3.18e-06	2.64e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—HMOX1—stomach cancer	3.14e-06	2.61e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK3—stomach cancer	3.13e-06	2.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—stomach cancer	3.12e-06	2.59e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—stomach cancer	3.1e-06	2.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS2—stomach cancer	3.08e-06	2.55e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TYMP—stomach cancer	3.05e-06	2.53e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—FADS1—stomach cancer	3.05e-06	2.53e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—stomach cancer	3.05e-06	2.53e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	3.04e-06	2.52e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAPK1—stomach cancer	3.03e-06	2.51e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—stomach cancer	3.03e-06	2.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1B—stomach cancer	3.02e-06	2.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB2—stomach cancer	3.02e-06	2.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—stomach cancer	3e-06	2.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—stomach cancer	2.99e-06	2.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CAV1—stomach cancer	2.99e-06	2.48e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAPK1—stomach cancer	2.98e-06	2.47e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—stomach cancer	2.98e-06	2.47e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APOA1—stomach cancer	2.98e-06	2.47e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—stomach cancer	2.97e-06	2.46e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—TYMS—stomach cancer	2.96e-06	2.46e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CD44—stomach cancer	2.96e-06	2.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—stomach cancer	2.95e-06	2.45e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—GSTM1—stomach cancer	2.93e-06	2.43e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CD44—stomach cancer	2.88e-06	2.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JUN—stomach cancer	2.88e-06	2.39e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.87e-06	2.38e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KRAS—stomach cancer	2.86e-06	2.37e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SREBF2—stomach cancer	2.86e-06	2.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRKCB—stomach cancer	2.84e-06	2.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6ST—stomach cancer	2.83e-06	2.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—RORA—stomach cancer	2.82e-06	2.34e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KRAS—stomach cancer	2.82e-06	2.34e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPP2R1A—stomach cancer	2.82e-06	2.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1B—stomach cancer	2.79e-06	2.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1A—stomach cancer	2.79e-06	2.32e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTP1—stomach cancer	2.76e-06	2.29e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ERCC2—stomach cancer	2.75e-06	2.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK8—stomach cancer	2.72e-06	2.26e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—HMOX1—stomach cancer	2.72e-06	2.26e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APC—stomach cancer	2.72e-06	2.26e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALDOB—stomach cancer	2.64e-06	2.19e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PIK3CA—stomach cancer	2.63e-06	2.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—MAPK3—stomach cancer	2.6e-06	2.16e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—MTHFR—stomach cancer	2.59e-06	2.15e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PIK3CA—stomach cancer	2.59e-06	2.15e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1A—stomach cancer	2.58e-06	2.14e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—TYMS—stomach cancer	2.57e-06	2.13e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—stomach cancer	2.54e-06	2.11e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—GSTM1—stomach cancer	2.54e-06	2.11e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6R—stomach cancer	2.53e-06	2.09e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.51e-06	2.08e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—stomach cancer	2.5e-06	2.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—stomach cancer	2.49e-06	2.07e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—MAPK1—stomach cancer	2.48e-06	2.06e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTP1—stomach cancer	2.46e-06	2.04e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALOX5—stomach cancer	2.46e-06	2.04e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPP2R1A—stomach cancer	2.45e-06	2.03e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—stomach cancer	2.43e-06	2.02e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—HMOX1—stomach cancer	2.43e-06	2.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DPYD—stomach cancer	2.42e-06	2.01e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTP1—stomach cancer	2.41e-06	2e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—stomach cancer	2.39e-06	1.99e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CAV1—stomach cancer	2.39e-06	1.98e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ERCC2—stomach cancer	2.39e-06	1.98e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—APOA1—stomach cancer	2.38e-06	1.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK3—stomach cancer	2.38e-06	1.97e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—HMOX1—stomach cancer	2.37e-06	1.97e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SERPINE1—stomach cancer	2.36e-06	1.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—KRAS—stomach cancer	2.34e-06	1.94e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—stomach cancer	2.33e-06	1.93e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—stomach cancer	2.3e-06	1.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—stomach cancer	2.29e-06	1.9e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—TYMS—stomach cancer	2.29e-06	1.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RHOA—stomach cancer	2.28e-06	1.89e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—GSTM1—stomach cancer	2.26e-06	1.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—MAPK1—stomach cancer	2.26e-06	1.88e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—stomach cancer	2.26e-06	1.87e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—MTHFR—stomach cancer	2.24e-06	1.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—TYMS—stomach cancer	2.24e-06	1.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—GSTM1—stomach cancer	2.21e-06	1.83e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MAPK3—stomach cancer	2.2e-06	1.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PIK3CA—stomach cancer	2.15e-06	1.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KRAS—stomach cancer	2.14e-06	1.77e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTT1—stomach cancer	2.14e-06	1.77e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—stomach cancer	2.14e-06	1.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ERCC2—stomach cancer	2.13e-06	1.77e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.11e-06	1.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB2—stomach cancer	2.11e-06	1.75e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—stomach cancer	2.1e-06	1.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MAPK1—stomach cancer	2.09e-06	1.73e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ERCC2—stomach cancer	2.08e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CAV1—stomach cancer	2.07e-06	1.72e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—APOA1—stomach cancer	2.06e-06	1.71e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.06e-06	1.71e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO1—stomach cancer	2e-06	1.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—stomach cancer	2e-06	1.66e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—MTHFR—stomach cancer	2e-06	1.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—stomach cancer	1.99e-06	1.65e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.98e-06	1.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—KRAS—stomach cancer	1.97e-06	1.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PIK3CA—stomach cancer	1.96e-06	1.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1B—stomach cancer	1.96e-06	1.62e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—MTHFR—stomach cancer	1.95e-06	1.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—stomach cancer	1.9e-06	1.58e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—stomach cancer	1.89e-06	1.57e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCND1—stomach cancer	1.87e-06	1.55e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JUN—stomach cancer	1.86e-06	1.54e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CAV1—stomach cancer	1.85e-06	1.53e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—APOA1—stomach cancer	1.84e-06	1.53e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—stomach cancer	1.82e-06	1.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—stomach cancer	1.82e-06	1.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PIK3CA—stomach cancer	1.81e-06	1.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—stomach cancer	1.81e-06	1.5e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—stomach cancer	1.81e-06	1.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1A—stomach cancer	1.8e-06	1.5e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CAV1—stomach cancer	1.8e-06	1.5e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—APOA1—stomach cancer	1.8e-06	1.49e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CD44—stomach cancer	1.78e-06	1.47e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK8—stomach cancer	1.76e-06	1.46e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—stomach cancer	1.74e-06	1.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—stomach cancer	1.68e-06	1.39e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—stomach cancer	1.65e-06	1.37e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—stomach cancer	1.64e-06	1.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—stomach cancer	1.63e-06	1.35e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—stomach cancer	1.62e-06	1.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—stomach cancer	1.61e-06	1.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—stomach cancer	1.61e-06	1.33e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—stomach cancer	1.58e-06	1.31e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—stomach cancer	1.56e-06	1.3e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK3—stomach cancer	1.54e-06	1.28e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.51e-06	1.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—stomach cancer	1.5e-06	1.24e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTP1—stomach cancer	1.48e-06	1.23e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAPK1—stomach cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—HMOX1—stomach cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—stomach cancer	1.46e-06	1.21e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—stomach cancer	1.43e-06	1.19e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—stomach cancer	1.42e-06	1.18e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—stomach cancer	1.4e-06	1.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KRAS—stomach cancer	1.38e-06	1.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—TYMS—stomach cancer	1.38e-06	1.14e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—stomach cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—GSTM1—stomach cancer	1.36e-06	1.13e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ERCC2—stomach cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—stomach cancer	1.28e-06	1.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CA—stomach cancer	1.27e-06	1.05e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—stomach cancer	1.25e-06	1.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—stomach cancer	1.23e-06	1.02e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—MTHFR—stomach cancer	1.2e-06	9.99e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—stomach cancer	1.18e-06	9.75e-06	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—stomach cancer	1.12e-06	9.33e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CAV1—stomach cancer	1.11e-06	9.21e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—APOA1—stomach cancer	1.11e-06	9.19e-06	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CA—stomach cancer	1.02e-06	8.43e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—stomach cancer	9.76e-07	8.1e-06	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CA—stomach cancer	8.8e-07	7.3e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—stomach cancer	8.78e-07	7.28e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—stomach cancer	8.4e-07	6.96e-06	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CA—stomach cancer	7.86e-07	6.52e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—stomach cancer	7.68e-07	6.37e-06	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CA—stomach cancer	7.67e-07	6.36e-06	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CA—stomach cancer	4.72e-07	3.92e-06	CbGpPWpGaD
